Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Blood Specimen Collection 13Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Surgical Procedures, Operative 3Pirinitramide 2Morphine 2Bevacizumab 2ribociclib 1lanreotide 1jinfukang 1eribulin 1cabazitaxel 1Zoledronic Acid 1Vinorelbine 1Trastuzumab 1Thiotepa 1Taxes 1Stem Cell Transplantation 1Standard of Care 1Spinal Puncture 1Sorafenib 1Radiofrequency Ablation 1Propofol 1Pemetrexed 1Octreotide 1Letrozole 1Lapatinib 1Injections, Epidural 1Injections 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplastic Cells, Circulating × Pirinitramide × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡